FDA approves new psoriasis drug Stelara
Stelara offers patients a new treatment option
September 25, 2009
Stelara, a new drug for treating moderate to severe psoriasis in adults, was approved today by the U.S. Food and Drug Administration. Known by the generic name ustekinumab, the drug is injected in the skin, and works by blocking part of the body's immune system.
Stelara is a "very significant medication," said Dr. Craig Leonardi, a dermatologist in St. Louis, Mo. who served as a lead investigator in clinical trials for the drug. Leonardi believes Stelara is particularly effective for patients who've seen little or no response to treatments with other medications.
Shared via AddThis
No comments:
Post a Comment